Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment...
8 insider purchases on record · latest filing 2020-10-16.
Insiders have also filed 189 sale transactions at HRMY.